## EXE: Expand Energy Corporation - XLE: Energy

### Executive Summary

VALUE thesis: PEG 0.24 indicates fundamental undervaluation. Consistent execution (3/4 quarters beat estimates). Caution: momentum weakening (-7.1% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($106.95)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Bank of Nova Scotia (NYSE:BNS) Shares Little Changed in Trade**
- Source: Kalkine Media | 20251209T210930 | Neutral | Relevance: 72%
- This article from Kalkine Media reports that Bank of Nova Scotia (NYSE:BNS) shares saw little change in trading. It provides an overview of the bank's operations, including its financial services sector involvement, international presence, and segmented structure covering domestic and international banking, wealth management, and market-related functions. The piece appears to be a factual, neutral presentation of the bank's profile.

**2. How Is Coterra Energy's Stock Performance Compared to Other Oil & Gas E&P Stocks?**
- Source: inkl | 20251210T150735 | Somewhat-Bullish | Relevance: 65%
-  Coterra Energy Inc. (CTRA) is a large-cap independent oil and gas company whose stock has outperformed the iShares U.S. Oil & Gas Exploration & Production ETF (IEO) over the past three months and 52 weeks, but slightly lagged IEO year-to-date. Despite underperforming some rivals like Expand Energy Corporation (EXE), analysts maintain a "Strong Buy" rating for CTRA with a significant upside potential based on their mean price target. The company's Q3 2025 results, which included strong production and reaffirmed free cash flow guidance, contributed to a nearly 6% stock climb.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-18 | Piper Sandler | $138 | $136 | +1% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-18 | Piper Sandler | main | Overweight |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 47.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 11.7% (+2.4%)
- Blackrock Inc.: 8.6% (+4.2%)
- Capital Research Glo: 6.7% (+161.5%)
- State Street Corpora: 5.5% (+8.3%)
- Price (T.Rowe) Assoc: 4.6% (-10.5%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-7.1% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.24 indicates undervaluation relative to growth. Forward P/E 12.0x attractive for 63% earnings growth. Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $27.2B |
| Beta | 0.44 |
| 52W Range | $91.02 - $126.62 |
| Short Interest | 4.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.24 |
| Forward P/E | 12.0 |
| Current P/E | 19.5 |
| YoY Growth | 62.9% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from 1.8% to -5.3% (-7.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 9.3pp (needs >4.0% for momentum thesis). AM_20 at -3.3% indicates price below own 20MA trend. Underperforming sector by 4.5pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.07x) but short-term weakness (below SMA20). MACD histogram bearish (-0.95), momentum weakening. RSI neutral at 46.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -5.34% (CS: 9) | Weak |
| RSI_14 | 46.5 | Neutral |
| MACD Histogram | -0.95 | Bearish |
| vs SMA20 | 0.967x | Below |
| vs SMA50 | 1.028x | Above |
| vs SMA200 | 1.068x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $114.33
- **Stop Loss:** $106.95 (6.5% risk)
- **Target:** $129.09 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 186
- **Position Value:** $21,265.38
- **Portfolio %:** 21.27%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-24 (Est: $1.58)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.85 | $0.97 | +14.2% |
| 2025Q2 | $1.15 | $1.10 | -4.1% |
| 2025Q1 | $1.87 | $2.02 | +8.0% |
| 2024Q4 | $0.47 | $0.55 | +17.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*